Literature DB >> 2726275

The dimensions of pain: a multidimensional scaling comparison of cancer patients and healthy volunteers.

Crawford W Clark1, Theresa Ferrer-Brechner, Malvin N Janal, Douglas J Carroll, Joseph C Yang.   

Abstract

This paper presents a new approach to the measurement and understanding of clinical pain. A multidimensional scaling (MDS) procedure was used to analyze pairwise similarity judgments made to 9 pain descriptors by 24 cancer pain patients and 24 healthy volunteers. The question was whether the dimensions of the global pain space differed between the 2 groups. The Pain Intensity dimension was found to be primary for the patients, but much less important for the volunteers. Otherwise, the group stimulus space revealed broadly similar 3-dimensional solutions. The Pain Intensity dimension placed Mild Pain and Annoying at one pole and Intense and Unbearable Pain at the other. The Emotional Quality dimension grouped the descriptors Sickening and Miserable (and, in part, Intense Pain and Unbearable Pain) at the strong negative affect pole for both groups; they differed, however, with respect to the moderate affect pole. The Somatosensory dimension ranged from Burning to Cramping. The subject weight space revealed that the Pain Intensity dimension was the most important dimension for the patients, while Emotional Quality was more salient for the volunteers. Wide differences were found in the salience of the various dimensions to different individuals; this information may prove useful for tailoring patient treatment. The study demonstrates that MDS procedures such as INDSCAL, in which the subjects (rather than the researcher) determine the number and characteristics of the global pain dimensions, will improve our understanding and treatment of pain.

Entities:  

Mesh:

Year:  1989        PMID: 2726275     DOI: 10.1016/0304-3959(89)90149-8

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  8 in total

1.  Multidimensional scaling of painful and innocuous electrocutaneous stimuli: reliability and individual differences.

Authors:  M N Janal; W C Clark; J D Carroll
Journal:  Percept Psychophys       Date:  1991-08

2.  Breast Cancer EDGE Task Force Outcomes: Clinical Measures of Pain.

Authors:  Shana Harrington; Laura Gilchrist; Antoinette Sander
Journal:  Rehabil Oncol       Date:  2014

3.  In memoriam, J. Douglas Carroll 1939-2011.

Authors:  Willem J Heiser
Journal:  Psychometrika       Date:  2013-01       Impact factor: 2.500

4.  Confirmatory factor analysis of brief pain inventory (BPI) functional interference clusters in patients with bone metastases.

Authors:  Edward Chow; Jennifer James; Andrea Barsevick; William Hartsell; Sarah Ratcliffe; Charles Scarantino; Robert Ivker; John Suh; Ivy Petersen; Andre Konski; William Demas; Deborah Bruner
Journal:  J Pain Manag       Date:  2010

5.  Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers.

Authors:  Sandra D Comer; Ziva D Cooper; William J Kowalczyk; Maria A Sullivan; Suzette M Evans; Adam M Bisaga; Suzanne K Vosburg
Journal:  Psychopharmacology (Berl)       Date:  2009-10-27       Impact factor: 4.530

6.  The visual time analog scale: simple, novel measurement approach to assess pain in patients with chronic pain.

Authors:  Akiko Okifuji; Reiko Mitsunaga; Yuri Kida; Gary W Donaldson
Journal:  Pain Manag       Date:  2021-02-15

7.  Contemporary English Pain Descriptors as Detected on Social Media Using Artificial Intelligence and Emotion Analytics Algorithms: Cross-sectional Study.

Authors:  Ming Yi Tan; Charlene Enhui Goh; Hee Hon Tan
Journal:  JMIR Form Res       Date:  2021-11-25

8.  Pain point system scale (PPSS): a method for postoperative pain estimation in retrospective studies.

Authors:  Anastasia Gkotsi; Dimosthenis Petsas; Vasilios Sakalis; Asterios Fotas; Argyrios Triantafyllidis; Ioannis Vouros; Evangelos Saridakis; Georgios Salpiggidis; Athanasios Papathanasiou
Journal:  J Pain Res       Date:  2012-11-07       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.